MedPath

BILLEV PHARMA ApS

BILLEV PHARMA ApS logo
🇩🇰Denmark
Ownership
Private
Established
1978-01-01
Employees
11
Market Cap
-
Website
https://billevpharma.dk

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

5

CIMA_AEMPS:4
EMA:1

Drug Approvals

Lutetium (177Lu) chloride Billev (previously Illuzyce)

Authorization Status
Authorised
Approval Date
Sep 15, 2022
EMA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.